Using a PyMT model, a robust transgenic model of highly metastatic mammary carcinoma that closely resembles human breast cancer of high grade and aggressive disease outcomes, the same group showed that low expression levels of ADAMTS15 together with high expression of ADAMTS8 were associated with poor clinical outcome [169]. The gene discussed is ADAMTS8; the disease is breast cancer.